MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy

Jaeseung Shin1, Nieun Seo1, Song-Ee Baek1

  • 1From the Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea (J.S., N.S., S.E.B., J.S.L., S.K.); Data Science Team, Center for Digital Health, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea (N.H.S.); and Departments of Surgical Oncology (N.K.K.) and Radiation Oncology (W.S.K.), Yonsei University College of Medicine, Seoul, South Korea.

Radiology
|February 8, 2022
PubMed
Summary

An MRI radiomics model accurately predicts pathologic complete response (pCR) in locally advanced rectal cancer (LARC) after neoadjuvant chemoradiotherapy (nCRT). This AI-driven approach outperforms radiologists in diagnosing pCR, aiding organ preservation decisions.